Cordyceps Sinensis Market -
Regional Insights
Geographically, the global Cordyceps
Sinensis Extract Market is segmented into North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa. North America is expected to
lead the market during the forecast period, followed by Europe.
High prevalence of chronic
diseases in the U.S. is expected to be a major factor supporting the market
growth. According to Centre for Disease Control and Prevention, seven of the
top ten causes of deaths in the U.S., in 2014 were chronic diseases, heart
diseases, and cancer, which together accounted for over 46% of the deaths in
the country. Furthermore, increasing number of patients with mental disorders
is expected to significantly expand adoption of cordyceps sinensis extracts as
it has immense benefits in lowering symptoms related to mental disorder.
According to Anxiety and Depression Association of America in 2017, anxiety
disorders are the most common mental illness in the U.S., affecting around 40
million adults aged 18 years and above, or 18.1% of the population, annually.
However, only 36.9% of those suffering from anxiety receive treatment.
Asia Pacific is expected to show
significant growth in the global cordyceps sinensis extract market over the
forecast period. This is due the region being a major producer of cordyceps
sinensis extracts, especially in China. According to data presented by the
Ministry of Agriculture and Rural Affairs of the Peoples Republic of China in
2011, China has 200,000 kg of Cordyceps and 120,000 kg was harvested. Qinghai
and Tibet regions exports around 20,000 kg of cordyceps sinensis to the U.S.,
Japan, Korea, Europe, South East Asia, Hong Kong, Macao and Taiwan etc. with an
annual export of over 20,000 kg.
Furthermore, rising prevalence of chronic diseases and increasing
adoption of traditional medicines for the treatment of such diseases in the
region is expected to propel growth of the cordyceps sinensis extract market.
As per World Health Organizations’ factsheet in 2018, 1 in 3
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1983
Cordyceps Sinensis also called as
ophiocordyceps sinensis is combination of parasitic fungus species and dead
caterpillars that offer several potential health applications. It has been in
use in traditional Chinese and Tibetan medicines as remedy for around 21
ailments such as low immunity, high blood pressure etc. Cordyceps spores grows
inside the caterpillar’s body and infects it, thus slowly degrading the living
larva and mummifies it in the soil. A cordyceps stem eventually emerges from
head part of the caterpillar.
Major active ingredients in
cordyceps sinensis extract include cordycepin, adenosine, exopolysaccharide
fraction (EPSF), cordyglucans, and monosaccharide saponin. Scientific studies
and clinical trials found that cordyceps sinensis extract can aid treatment of
diabetes, high cholesterol, and hypertension. Furthermore, it boosts immunity
and acts as stress reliever in stress related disorders.
Cordyceps Sinensis is available as health
supplement in tablet, powder, and capsule form in major developed markets.
Regulatory bodies such as USFDA has have approved use of cordyceps sinensis
extract as dietary supplement.
Cordyceps Sinensis Market -
Market Dynamics
Cordyceps sinensis offers
medicinal properties such as cholesterol reduction, stimulation of the immune
system, faster recovery from bronchitis, and other respiratory diseases, and
increases efficiency of the circulatory system. Furthermore, it has anti-cancer
properties and can be used in treatment of liver-associated diseases. It
provides enhanced recovery from chemotherapy, improves libido, a general body
adaptogen (enhanced body energy and strength)
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/cordyceps-sinensis-extract-market-1983
High prevalence of chronic
diseases such as cardiovascular disease, cancer, diabetes, and respiratory
diseases would lead to increasing adoption of preventive healthcare products
made from cordyceps sinensis extracts, which in turn would aid in growth of the
cordyceps sinensis extract market. According to World Health Organizations
statistics, in 2018, non-communicable diseases are responsible for over 41 million
deaths, annually, which is equivalent to 71% of all deaths, worldwide.
Furthermore, according to the same source cardiovascular diseases causes over
17.9 million deaths annually, followed by cancer (9.0 million), respiratory
diseases (3.9million), and diabetes (1.6 million), respectively.
High prevalence of autoimmune and
stress related disorders across the world, especially in developed regions such
as North America and Europe. According to American Autoimmune Related Disease
Association, more than 50 million people in the U.S. were affected by
autoimmune disease in 2017. This would be another major factor driving growth
of the cordyceps sinensis extract market. Increased preference for natural
remedy for correcting chronic disease is new trend in world including U.S.
However, high cost of cordyceps
sinensis extracts is expected to be a major factor deterring the market growth.
Insufficient clinical evidence for many diseases such as cancer and diabetes
may limit market growth for cordyceps sinensis extract. Furthermore, it is
difficult to scale up the artificial cultivation of cordyceps sinensis species.
High cost of cordyceps sinensis in the international market often leads to
malpractice of adulteration and substitution in the extracts.
Cordyceps Sinensis Market -
Competitive Landscape
Key players operating in the
global cordyceps sinensis market include Naturalin, Active Organics, Quyuan
sunnycare Inc., Kangzhou, HERBSINO, SOST, Health Choice Limited, Zhongke Group,
and Nutra Green.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/1983
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment